Next Generation News and Research

RSS

Pulmatrix reports positive results from initial PUR0200 Phase IB clinical study in COPD

Pulmatrix today announced the successful completion and positive results of the first part of a two-part Phase IB clinical study in chronic obstructive pulmonary disease (COPD) patients with their lead clinical candidate PUR0200.

29 Oct 2013

Peds21 symposium discusses role of parents, caregivers and early childhood experiences in shaping future health

Recent research has found that a dramatic dance between genes and experience shape the architecture of the developing brain, most profoundly during the first 1,000 days of life.

25 Oct 2013

Transcatheter Technologies reports first-in-human implantation of transapical TRINITY aortic valve

Transcatheter Technologies GmbH, a emerging medical device company that is developing a next-generation transcatheter aortic heart valve prosthesis, announced today the successful first-in-human implantation of its transapical TRINITY aortic valve designed to be the world's best repositionable heart valve.

25 Oct 2013

Johns Hopkins joins with imec to advance silicon applications in health care

Researchers and physicians at The Johns Hopkins University will collaborate with Belgian nanoelectronics research center imec to advance silicon applications in health care, beginning with development of a point-of-care device to enable a broad range of clinical tests to be performed outside the laboratory.

25 Oct 2013

Illumina announces launch of TruGenome Undiagnosed Disease Test

Illumina, Inc. today announced the launch of its TruGenome Undiagnosed Disease Test provided by the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory.

From Illumina, Inc. 22 Oct 2013

New investigational drug offers potential treatment option for lung cancer

PF-06463922, an investigational drug being developed by Pfizer Inc., has the potential to become a new treatment option for patients who have lung cancer harboring abnormalities in the ALK gene, according to preclinical results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.

21 Oct 2013

Advaxis announces full exercise of over-allotment option granted to underwriters

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 862,500 shares of its common stock and warrants to purchase an additional 431,250 shares (15% of the shares and warrants sold in this offering), at a public offering price of $4.00 per share and $0.001 per warrant, respectively, in connection with its previously announced underwritten public offering of 5,750,000 shares of common stock, and warrants to purchase up to an aggregate of 2,875,000 shares of common stock, bringing the total gross proceeds from the offering to approximately $26,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by Advaxis, Inc.

19 Oct 2013

Astrazeneca, Taiwan's NRPB Launch Drug Discovery Collaboration

...

18 Oct 2013

Astrazeneca, Taiwan's NRPB Launch Drug Discovery Collaboration

...

17 Oct 2013

Viewpoints: Young people could spark needed entitlement changes; Priebus demands that Sebelius go; GOP's 'absurd debate' on Hill health coverage

Eventually this shutdown crisis will end. And eventually the two parties will make another stab at a deal on taxes, investments and entitlements. But there's one outcome from such negotiations that I can absolutely guarantee: Seniors, Wall Street and unions will all have their say and their interests protected. So the most likely result will be more tinkering around the edges, as our politicians run for the hills the minute someone accuses them of "fixing the deficit on the backs of the elderly" or creating "death panels" to sensibly allocate end-of-life health care.

17 Oct 2013

Duke University launches new HIV/AIDS specialty concentration within Primary Care Nurse Practitioner

Duke University School of Nursing is currently accepting applications for its new HIV/AIDS specialty concentration within the Primary Care Nurse Practitioner major for the fall 2014 semester.

17 Oct 2013

Cedars-Sinai awards $3.3M grants to organizations dedicated to community health, education and safety

Cedars-Sinai is awarding $3.3 million in grants to organizations dedicated to community health, education and safety for projects that will benefit residents in neighborhoods throughout Los Angeles, including South Los Angeles, West Hollywood and Venice.

17 Oct 2013

Imaxio Sells Genomics Division To Hybrigenics

...

16 Oct 2013

Pieris, Zydus Cadila partner to develop and commercialize Anticalin-based protein therapeutics

Zydus Cadila, an innovative global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare products, and Pieris AG, a next generation therapeutic protein R&D company, have entered into an alliance for development and commercialization of multiple novel Anticalin-based protein therapeutics, both companies announced today.

16 Oct 2013

Two institutions receive $25M grant from NIH to abet clinical and translational research

Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have received a $25 million grant from the National Institutes of Health (NIH) for the Harold and Muriel Block Institute for Clinical and Translational Research (ICTR) at Einstein and Montefiore.

16 Oct 2013

Astrazeneca Acquires Spirogen For Up To $440M

...

15 Oct 2013

Affiliate of Channel Technologies Group buys assets of H.C. Materials

An affiliate of Channel Technologies Group, LLC, a manufacturer of piezoelectric ceramics, transducers and complex sonar and navigation systems used in the defense, medical and energy industries, today announced it has acquired the assets of H.C. Materials Inc. and its affiliates (collectively, "HCM") from Dr. Pengdi Han.

12 Oct 2013

Olympus launches forward-viewing curvilinear ultrasound gastrovideoscope

Olympus, a precision technology leader in designing and delivering innovative solutions in the medical and surgical field, among other core businesses, announced today the launch of its 510(k) cleared and world's only forward-viewing curvilinear ultrasound gastrovideoscope.

From Evident Corporation - Life Sciences 10 Oct 2013

Allegro receives FDA IND approval to initiate Phase II clinical studies of ALG-1001 in AMD, VMT patients

Allegro Ophthalmics, LLC, a company dedicated to establishing Integrin Peptide Therapy as the next-generation pharmaceutical category for the treatment of vascular eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to begin two Phase II clinical studies of ALG-1001.

10 Oct 2013

Catalyst, Isu Abxis To Develop Hemophilia B Candidate

...

9 Oct 2013

Next Generation News and Research

Pulmatrix reports positive results from initial PUR0200 Phase IB clinical study in COPD

Peds21 symposium discusses role of parents, caregivers and early childhood experiences in shaping future health

Transcatheter Technologies reports first-in-human implantation of transapical TRINITY aortic valve

Johns Hopkins joins with imec to advance silicon applications in health care

Illumina announces launch of TruGenome Undiagnosed Disease Test

New investigational drug offers potential treatment option for lung cancer

Advaxis announces full exercise of over-allotment option granted to underwriters

Astrazeneca, Taiwan's NRPB Launch Drug Discovery Collaboration

Astrazeneca, Taiwan's NRPB Launch Drug Discovery Collaboration

Viewpoints: Young people could spark needed entitlement changes; Priebus demands that Sebelius go; GOP's 'absurd debate' on Hill health coverage

Duke University launches new HIV/AIDS specialty concentration within Primary Care Nurse Practitioner

Cedars-Sinai awards $3.3M grants to organizations dedicated to community health, education and safety

Imaxio Sells Genomics Division To Hybrigenics

Pieris, Zydus Cadila partner to develop and commercialize Anticalin-based protein therapeutics

Two institutions receive $25M grant from NIH to abet clinical and translational research

Astrazeneca Acquires Spirogen For Up To $440M

Affiliate of Channel Technologies Group buys assets of H.C. Materials

Olympus launches forward-viewing curvilinear ultrasound gastrovideoscope

Allegro receives FDA IND approval to initiate Phase II clinical studies of ALG-1001 in AMD, VMT patients

Catalyst, Isu Abxis To Develop Hemophilia B Candidate

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News